Patient Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB, which includes delamanid and bedaquiline. Khayelitsha, Western Cape.
All Topics

Drug-resistant TB

 
MSF_Protest_At_J&J_Offices_In_SA_MSF288569
Access to medicines

MSF calls again on J&J to withdraw/abandon extended patents on lifesaving TB drug

Latest News 18 Jul 2023
 
MSF, Doctors Without Borders, TB
Tuberculosis

TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries

Press Release 14 Jul 2023
 
MSF_HIV_AND_TB_PROJECT_SWAZILAND_ESWATINI
HIV/TB Integration

“Despite the challenges I've faced, my determination to aid patients has grown"

Fieldworkers Stories 15 Jun 2023
 
Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB.
Drug-resistant TB

TAC and MSF intervene in a case for a lifesaving cystic fibrosis drug priced at over R5 million

Press Release 10 May 2023
 
MSF, Doctors Without Borders, Bedaqueline
Multi-drug Resistant Tuberculosis

MSF demands J&J give up its patent monopoly on TB drug to put lives over profits

Press Release 26 Apr 2023
 
MSF, Doctors Without Borders, India rejects Johnson & Johnson patent extension attempt
Drug-resistant TB

MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug

Press Release 23 Mar 2023